The European Commission plans to present the first biotech legislation by the end of 2025, with the intention of making the regulatory framework more favourable to innovation, accelerating clinical trial procedures and attracting researchers and investors. This is what European Commissioner for Health and Animal Welfare Olivér Várhelyi said on Wednesday 2 July when presenting the life sciences strategy (see EUROPE B13672A3).
“Biotechnology legislation was originally scheduled for 2026,...